• All
  • Primary Antibodies
  • Conjugated Antibodies for IF
  • Conjugated Antibodies for FC
  • Secondary Antibodies
  • Antibody Labeling KitsNew
  • ELISA Kits
  • IHC Kits
  • Magnetic Cell Separation Kits
  • Cytokines & Growth Factors
  • Neutralizing/activating Antibodies
  • Nanobody-based Reagents
  • Accessory Products and Kits
  • Fusion Proteins
×
×
Host
0
Species Reactivity
0
Species Reactivity
0
Conjugate
0
Conjugate
0
Compatible Species
0
Conjugate
0

PKR-IN-C16

CAS号

608512-97-6

分子式

C13H8N4OS

主要靶点

Others

仅限科研使用

Cat No : CM06234

Print datasheet

Synonyms

Inhibitor|PKRINC16|PKR-IN-C16|PKR-IN-C-16|PKR|PKR IN C16|SH-SY5Y|acute brain lesions|Apoptosis|inhibit

验证数据展示

  • CAS No.: 608512-97-6

    PKR-IN-C16
    CAS#: 608512-97-6

产品信息

CAS号 608512-97-6
分子式 C13H8N4OS
主要靶点 Others
主要通路 其他
分子量 268.29
纯度 97.80%， 此纯度可做参考，具体纯度与批次有关系，可咨询客服
储存条件 Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
别名 Inhibitor|PKRINC16|PKR-IN-C16|PKR-IN-C-16|PKR|PKR IN C16|SH-SY5Y|acute brain lesions|Apoptosis|inhibit

溶解度

DMSO:15.67 mg/mL (58.41 mM)

参考文献

1.Tronel C, et al. The specific PKR inhibitor C16 prevents apoptosis and IL-1β production in an acute excitotoxic rat model with a neuroinflammatory component. Neurochem Int. 2014 Jan;64:73-83.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
=
×
×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
×
=
×
C1   V1   C2   V2